3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
3
Colorectal Neoplasms
3
Lymphoma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Lymphoma, Follicular
1
Lewy Body Disease
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Carboplatin
69
Paclitaxel
63
Cisplatin
32
Topotecan
29
Gemcitabine
21
Docetaxel
20
Cyclophosphamide
18
Filgrastim
17
liposomal doxorubicin
15
Peripheral Blood Stem Cell Transplantation
15
Bevacizumab
14
sargramostim
11
Taxes
10
Drug Therapy
10
Therapeutics
7
Psychiatric Rehabilitation
7
Immunohistochemistry
7
Erlotinib Hydrochloride
7
Amifostine
7
Melphalan
6
Chemotherapy, Adjuvant
6
rucaparib
5
pembrolizumab
5
mirvetuximab soravtansine
5
ixabepilone
5
Surgical Procedures, Operative
5
Mass Spectrometry
5
Interleukin-12 Subunit p35
5
Flow Cytometry
5
Etoposide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Ovarian Epithelial
×
Referral and Consultation
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled